Stage IIIB Breast Cancer Recruiting Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02474173Onalespib and Paclitaxel in Treating Patients With Advanced Triple Negative Breast CancerTreatment